Apogee Therapeutics, Inc. APGE Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Apogee Therapeutics, Inc. (APGE) reported operating lease right-of-use assets in other assets of $7.71M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Apogee Therapeutics, Inc.'s operating lease right-of-use assets in other assets decreased by 33.0% year-over-year, from $11.51M to $7.71M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s operating lease right-of-use assets in other assets has grown at a 97.9% compound annual growth rate (CAGR), from $2.22M to $8.69M.